NTLA

• 11/8/2024

  “Unlock Intellia Therapeutics’ 354% Upside Potential: A Gene-Editing Gem?”

• 10/9/2024

  **2 Stocks with Massive Upside Potential: 32% and 282% Gains Forecasted**